Dr Michelle Miller is the CEO of Biotron which has an HIV drug. The company hit the jackpot in September with a phase two trial result that took the share price from 2 cents to 30 cents. Alan Kohler spoke to Dr Miller to find out more.

A weekly review of the Market Timing signals with Market Commentary and Technical Analysis.

This week on The Money Cafe, James Kirby and Alan Kohler discuss the impacts of America's midterm elections, some expensive stocks that may have become a bargain, why NAB has broken open the piggy bank to pay its dividends, and a whack of listener questions about franking credits.

In Talking Finance this week Alan Kohler chats to Shane Oliver, Chief Economist at AMP Capital and Tim Lawless, Head of Research at CoreLogic for a look at house prices. There's also markets with Kyle Rodda, Market Analyst at IG and a check of politics with David Marr, columnist for The Guardian.